Hck
Marca | Datos del producto | Pureza | Rango de precios | Entrega estimada |
---|---|---|---|---|
Hck-IN-1 REF: TM-T11538CAS: 1473404-51-1 | 98.29% | 128,00 €~1.323,00 € | Lun 15 Jul 24 | |
PP121 REF: TM-T2415CAS: 1092788-83-4 | 99.67% | 55,00 €~344,00 € | Lun 22 Jul 24 | |
TL02-59 REF: TM-T13186CAS: 1315330-17-6 | 98% | 104,00 €~1.132,00 € | Lun 16 Sep 24 |
Hck-IN-1
CAS:1473404-51-1
Hck-IN-1 is a selective Nef-dependent Hck inhibitor (IC50s: 2.8 μM and >20 μM for Nef:Hck …
Fórmula:
C16H11ClN6O3S
Pureza:
98.29%
Forma y color:
Solid
Peso molecular:
402.81
Ref: TM-T11538
1mg | 128,00 € | ||
2mg | 176,00 € | ||
5mg | 270,00 € | ||
10mg | 423,00 € | ||
25mg | 697,00 € | ||
50mg | 976,00 € | ||
100mg | 1.323,00 € | ||
1ml*10 (DMSO) | 291,00 € |
Entrega estimada en Estados Unidos, el Lunes 15 de Julio de 2024
PP121
CAS:1092788-83-4
PP-121 is a multi-targeted inhibitor of PDGFR (IC50: 2 nM), Hck (IC50: 8 nM), mTOR …
Fórmula:
C17H17N7
Pureza:
99.67%
Forma y color:
Solid
Peso molecular:
319.36
Ref: TM-T2415
5mg | 60,00 € | ||
10mg | 89,00 € | ||
25mg | 155,00 € | ||
50mg | 237,00 € | ||
100mg | 344,00 € | ||
1ml*10 (DMSO) | 55,00 € |
Entrega estimada en Estados Unidos, el Lunes 22 de Julio de 2024
TL02-59
CAS:1315330-17-6
TL02-59: Fgr inhibitor (IC50=0.03nM), also targets Lyn (0.1nM), Hck (160nM), halts acute myelogenous leukemia growth.
Fórmula:
C32H34F3N5O4
Pureza:
98%
Forma y color:
Solid
Peso molecular:
609.64
Ref: TM-T13186
1mg | 104,00 € | ||
1ml | 281,00 € | ||
5mg | 212,00 € | ||
10mg | 347,00 € | ||
25mg | 584,00 € | ||
50mg | 832,00 € | ||
100mg | 1.132,00 € |
Entrega estimada en Estados Unidos, el Lunes 16 de Septiembre de 2024